Cargando…

A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study

Intravesical Bacillus Calmette Guerin (BCG) is the gold standard therapy for intermediate/high-risk non-muscle invasive bladder cancer (NMIBC). However, the response rate is ~60%, and 50% of non-responders will progress to muscle-invasive disease. BCG induces massive local infiltration of inflammato...

Descripción completa

Detalles Bibliográficos
Autores principales: VILLOLDO, GUSTAVO MARTÍN, POMBO, MARÍA TERESA, ARIS, MARIANA, CHEMI, JOAQUÍN, MANDÓ, PABLO, NAGARAJU, SUPRIYA, CAMEAN, JUAN, BURIONI, ADRIÁN, EGEA, DEBORAH, AMAT, MORA, MELLADO, JOSÉ LEÓN, MORDOH, JOSÉ, VILLARONGA, ALBERTO, BARRIO, MARÍA MARCELA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tech Science Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208021/
https://www.ncbi.nlm.nih.gov/pubmed/37304240
http://dx.doi.org/10.32604/or.2023.028163
_version_ 1785046581670576128
author VILLOLDO, GUSTAVO MARTÍN
POMBO, MARÍA TERESA
ARIS, MARIANA
CHEMI, JOAQUÍN
MANDÓ, PABLO
NAGARAJU, SUPRIYA
CAMEAN, JUAN
BURIONI, ADRIÁN
EGEA, DEBORAH
AMAT, MORA
MELLADO, JOSÉ LEÓN
MORDOH, JOSÉ
VILLARONGA, ALBERTO
BARRIO, MARÍA MARCELA
author_facet VILLOLDO, GUSTAVO MARTÍN
POMBO, MARÍA TERESA
ARIS, MARIANA
CHEMI, JOAQUÍN
MANDÓ, PABLO
NAGARAJU, SUPRIYA
CAMEAN, JUAN
BURIONI, ADRIÁN
EGEA, DEBORAH
AMAT, MORA
MELLADO, JOSÉ LEÓN
MORDOH, JOSÉ
VILLARONGA, ALBERTO
BARRIO, MARÍA MARCELA
author_sort VILLOLDO, GUSTAVO MARTÍN
collection PubMed
description Intravesical Bacillus Calmette Guerin (BCG) is the gold standard therapy for intermediate/high-risk non-muscle invasive bladder cancer (NMIBC). However, the response rate is ~60%, and 50% of non-responders will progress to muscle-invasive disease. BCG induces massive local infiltration of inflammatory cells (Th1) and ultimately cytotoxic tumor elimination. We searched for predictive biomarker of BCG response by analyzing tumor-infiltrating lymphocyte (TIL) polarization in the tumor microenvironment (TME) in pre-treatment biopsies. Pre-treatment biopsies from patients with NMIBC who received adequate intravesical instillation of BCG (n = 32) were evaluated retrospectively by immunohistochemistry. TME polarization was assessed by quantifying the T-Bet+ (Th1) and GATA-3+ (Th2) lymphocyte ratio (G/T), and the density and degranulation of EPX+ eosinophils. In addition, PD-1/PD-L1 staining was quantified. The results correlated with BCG response. In most non-responders, Th1/Th2 markers were compared in pre-and post-BCG biopsies. ORR was 65.6% in the study population. BCG responders had a higher G/T ratio and a greater number of degranulated EPX+ cells. Variables combined into a Th2-score showed a significant association with higher scores in responders (p = 0.027). A Th2-score cut-off value >48.1 allowed discrimination of responders with 91% sensitivity but lower specificity. Relapse-free survival was significantly associated with the Th2-score (p = 0.007). In post-BCG biopsies from recurring patients, TILs increased Th2-polarization, probably reflecting BCG failure to induce a pro-inflammatory status and, thus, a lack of response. PD-L1/PD-1 expression was not associated with the response to BCG. Our results support the hypothesis that a pre-existing Th2-polarized TME predicts a better response to BCG, assuming a reversion to Th1 polarization and antitumor activity.
format Online
Article
Text
id pubmed-10208021
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Tech Science Press
record_format MEDLINE/PubMed
spelling pubmed-102080212023-06-10 A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study VILLOLDO, GUSTAVO MARTÍN POMBO, MARÍA TERESA ARIS, MARIANA CHEMI, JOAQUÍN MANDÓ, PABLO NAGARAJU, SUPRIYA CAMEAN, JUAN BURIONI, ADRIÁN EGEA, DEBORAH AMAT, MORA MELLADO, JOSÉ LEÓN MORDOH, JOSÉ VILLARONGA, ALBERTO BARRIO, MARÍA MARCELA Oncol Res Article Intravesical Bacillus Calmette Guerin (BCG) is the gold standard therapy for intermediate/high-risk non-muscle invasive bladder cancer (NMIBC). However, the response rate is ~60%, and 50% of non-responders will progress to muscle-invasive disease. BCG induces massive local infiltration of inflammatory cells (Th1) and ultimately cytotoxic tumor elimination. We searched for predictive biomarker of BCG response by analyzing tumor-infiltrating lymphocyte (TIL) polarization in the tumor microenvironment (TME) in pre-treatment biopsies. Pre-treatment biopsies from patients with NMIBC who received adequate intravesical instillation of BCG (n = 32) were evaluated retrospectively by immunohistochemistry. TME polarization was assessed by quantifying the T-Bet+ (Th1) and GATA-3+ (Th2) lymphocyte ratio (G/T), and the density and degranulation of EPX+ eosinophils. In addition, PD-1/PD-L1 staining was quantified. The results correlated with BCG response. In most non-responders, Th1/Th2 markers were compared in pre-and post-BCG biopsies. ORR was 65.6% in the study population. BCG responders had a higher G/T ratio and a greater number of degranulated EPX+ cells. Variables combined into a Th2-score showed a significant association with higher scores in responders (p = 0.027). A Th2-score cut-off value >48.1 allowed discrimination of responders with 91% sensitivity but lower specificity. Relapse-free survival was significantly associated with the Th2-score (p = 0.007). In post-BCG biopsies from recurring patients, TILs increased Th2-polarization, probably reflecting BCG failure to induce a pro-inflammatory status and, thus, a lack of response. PD-L1/PD-1 expression was not associated with the response to BCG. Our results support the hypothesis that a pre-existing Th2-polarized TME predicts a better response to BCG, assuming a reversion to Th1 polarization and antitumor activity. Tech Science Press 2023-04-10 /pmc/articles/PMC10208021/ /pubmed/37304240 http://dx.doi.org/10.32604/or.2023.028163 Text en © 2023 Villoldo et al. https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
VILLOLDO, GUSTAVO MARTÍN
POMBO, MARÍA TERESA
ARIS, MARIANA
CHEMI, JOAQUÍN
MANDÓ, PABLO
NAGARAJU, SUPRIYA
CAMEAN, JUAN
BURIONI, ADRIÁN
EGEA, DEBORAH
AMAT, MORA
MELLADO, JOSÉ LEÓN
MORDOH, JOSÉ
VILLARONGA, ALBERTO
BARRIO, MARÍA MARCELA
A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study
title A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study
title_full A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study
title_fullStr A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study
title_full_unstemmed A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study
title_short A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study
title_sort th2-score in the tumor microenvironment as a predictive biomarker of response to bacillus calmette guérin in patients with non-muscle invasive bladder carcinoma: a retrospective study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208021/
https://www.ncbi.nlm.nih.gov/pubmed/37304240
http://dx.doi.org/10.32604/or.2023.028163
work_keys_str_mv AT villoldogustavomartin ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT pombomariateresa ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT arismariana ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT chemijoaquin ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT mandopablo ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT nagarajusupriya ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT cameanjuan ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT burioniadrian ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT egeadeborah ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT amatmora ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT melladojoseleon ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT mordohjose ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT villarongaalberto ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT barriomariamarcela ath2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT villoldogustavomartin th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT pombomariateresa th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT arismariana th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT chemijoaquin th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT mandopablo th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT nagarajusupriya th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT cameanjuan th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT burioniadrian th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT egeadeborah th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT amatmora th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT melladojoseleon th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT mordohjose th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT villarongaalberto th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy
AT barriomariamarcela th2scoreinthetumormicroenvironmentasapredictivebiomarkerofresponsetobacilluscalmetteguerininpatientswithnonmuscleinvasivebladdercarcinomaaretrospectivestudy